Cellectricon, a services provider dedicated to advancing drug discovery and research in neuroscience, has become a member of SwedenBIO, a national non-profit association for Life Science in Sweden.
With members ranging from start-ups and SMEs to large enterprises, active within pharma, biotech, medtech and diagnostics research, Cellectricon is joining a dynamic network of companies.
“We are excited about the opportunities ahead and look forward to making valuable connections and further collaborations within the Swedish Life Science community” said Dr. Mattias Karlsson, CEO at Cellectricon.
“As a first activity as a member, we’ll be joining Swedish partners for events organized by SwedenBIO during the JP Morgan Healthcare week in San Francisco this January” he added.
For more information on SwedenBIO, visit:
https://swedenbio.se